Companies working to deliver oxytocin by inhaler in Africa where one in 10 women suffer excessive bleeding after childbirth
Irish domicile of target company an attraction for generic drug maker
Drugmaker seems a long way from the measured approach that has typified the tenure of Kelly Martin
Irish drugmaker announces two more deals plus plans to raise $800 million
Company says bid fails to properly value business
Cantillon: Success in selling redundant sites hides deeper shift in Irish pharma outlook
Company cites falling demand for products as patents expire
Manufacturing moving to Ringaskiddy facility, says company
Economist warns of 25 per cent rise in premiums if charges imposed in public hospitals
Irish pharmaceutical company agrees to buy 21% of royalty Theravance receives from GSK
Fears over generic competition worry investors